Literature DB >> 18477763

Association of glycosylphosphatidylinositol-anchored protein with retroviral particles.

Christoph Metzner1, Meike M Mostegl, Walter H Günzburg, Brian Salmons, John A Dangerfield.   

Abstract

We describe for the first time the association of glycosylphosphatidylinositol (GPI) -anchored proteins with retroviral and lentiviral particles, similar to a process well established for cells, termed "painting." The aim of the study was to assess the feasibility of modification of retroviral vectors by exogenous addition of recombinant protein, removing the need for genetic engineering of virus producer cell lines. The recombinant GPI protein CD59his was purified via fast protein liquid chromatography and associated with concentrated virus stock in a controlled incubation procedure. Reaction mixtures were purified in order to remove nonassociated GPI protein and endogenous protein. Analysis of samples by immunoblotting revealed that CD59his was only detectable in the presence of viral particles. From this, we conclude that CD59his could be stably associated with retroviral particles. In addition, we demonstrated by flow cytometry that virus particles remain infectious after these procedures. As well as suggesting a novel possibility for interaction between enveloped virus and host, we believe that the stable association of recombinant GPI proteins to retroviral particles can be developed into an important tool for both research and clinical applications, especially in the fields of gene therapy and vaccine development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18477763     DOI: 10.1096/fj.08-108217

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  12 in total

1.  Design of hybrid lipid/retroviral-like particle gene delivery vectors.

Authors:  Rahul K Keswani; Ian M Pozdol; Daniel W Pack
Journal:  Mol Pharm       Date:  2013-03-26       Impact factor: 4.939

2.  Microvesicles/exosomes as potential novel biomarkers of metabolic diseases.

Authors:  Günter Müller
Journal:  Diabetes Metab Syndr Obes       Date:  2012-08-07       Impact factor: 3.168

3.  Imaging of mobile long-lived nanoplatforms in the live cell plasma membrane.

Authors:  Mario Brameshuber; Julian Weghuber; Verena Ruprecht; Imre Gombos; Ibolya Horváth; László Vigh; Paul Eckerstorfer; Endre Kiss; Hannes Stockinger; Gerhard J Schütz
Journal:  J Biol Chem       Date:  2010-10-21       Impact factor: 5.157

Review 4.  Fluorosomes: fluorescent virus-like nanoparticles that represent a convenient tool to visualize receptor-ligand interactions.

Authors:  Daniela Wojta-Stremayr; Winfried F Pickl
Journal:  Sensors (Basel)       Date:  2013-07-08       Impact factor: 3.576

5.  Immune Protection of Retroviral Vectors Upon Molecular Painting with the Complement Regulatory Protein CD59.

Authors:  Susanne Heider; Sandra Kleinberger; Feliks Kochan; John A Dangerfield; Christoph Metzner
Journal:  Mol Biotechnol       Date:  2016-07       Impact factor: 2.695

6.  Surface Modification of E. coli Outer Membrane Vesicles with Glycosylphosphatidylinositol-Anchored Proteins: Generating Pro/Eukaryote Chimera Constructs.

Authors:  Marianne Zaruba; Lena Roschitz; Haider Sami; Manfred Ogris; Wilhelm Gerner; Christoph Metzner
Journal:  Membranes (Basel)       Date:  2021-06-04

Review 7.  Postexit surface engineering of retroviral/lentiviral vectors.

Authors:  Christoph Metzner; Feliks Kochan; John A Dangerfield
Journal:  Biomed Res Int       Date:  2013-04-17       Impact factor: 3.411

8.  Fluorescence molecular painting of enveloped viruses.

Authors:  Christoph Metzner; Feliks Kochan; John A Dangerfield
Journal:  Mol Biotechnol       Date:  2013-01       Impact factor: 2.695

Review 9.  Quantitative real-time single particle analysis of virions.

Authors:  Susanne Heider; Christoph Metzner
Journal:  Virology       Date:  2014-07-05       Impact factor: 3.616

Review 10.  Biomedical applications of glycosylphosphatidylinositol-anchored proteins.

Authors:  Susanne Heider; John A Dangerfield; Christoph Metzner
Journal:  J Lipid Res       Date:  2016-08-19       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.